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Edited by Gianni CesareniAbstract Janus kinase (JAK) signal transducers, and activa-
tors of transcription (STAT), contribute to diabetic nephropa-
thy. Here we show that one of the suppressors of cytokine
signaling (SOCS) proteins, SOCS-1, was upregulated in human
mesangial cells (HMCs) under high glucose conditions, along
with the activation of JAK2, STAT1, and STAT3. Overexpres-
sion of SOCS-1 in HMCs inhibited HG-induced JAK2/STAT
activation, c-Fos/c-Jun expression, and increased synthesis of
TGF-b1 and ﬁbronectin. These data suggest that SOCS-1 inhib-
its HG-induced overexpression of TGF-b1 and synthesis of ﬁbro-
nectin in HMC, which may be via JAK/STAT pathway.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: High glucose; SOCS-1; JAK2/STAT; Glomerular
mesangial cell1. Introduction
Diabetic nephropathy (DN) is one of the common causes of
end-stage renal disease, which encompasses a complex of path-
ological changes, including renal hypertrophy, accumulation
of extracellular matrical components, glomerulosclerosis,
tubular atrophy and interstitial ﬁbrosis. A basic mechanism
underlying diabetic nephropathy appears to be the high glu-
cose (HG)-induced overexpression of transforming growth
factor-b (TGF-b) and the accumulation of extracellular matrix
(ECM) molecules, such as collagen IV and ﬁbronectin [1,2].
Recent studies suggest that Janus kinase (JAK)/signal trans-
ducers and activators of transcription (STAT) signaling cas-
cades may contribute to diabetic nephropathy [3]. This
pathway is mainly related to renal cell growth, production of
the cytokine, TGF-b, as well as the ECM proteins collagen
IV and ﬁbronectin [4,5]. Wang et al. [4] reported that the acti-
vation of JAK2 and STAT1 proteins was a requirement for theAbbreviations: SOCS, suppressor of cytokine signaling; HG, high
glucose; HMC, human mesangial cell; DN, diabetic nephropathy;
ECM, extracellular matrix; JAK, Janus kinase; STAT, signal trans-
ducers and activators of transcription
*Corresponding author. Fax: +86 311 86266942.
E-mail address: duanhj999@163.com (H. Duan).
1These two authors contributed equally to this work.
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.09.014hyperglycemia-induced production of TGF-b and ﬁbronectin
in rat glomerular mesangial cells.
JAK/STAT pathway is an essential intracellular mechanism
of cytokine actions and constitutes a link between activation
of cell surface receptors and nuclear transcriptional event
[6,7]. Control of the magnitude and duration of cytokine signal-
ing is essential to prevent tissue damage. In this sense, recent
studies have shown that JAK/STAT signaling can be regulated
at many steps through diﬀerent mechanisms [7]. The suppres-
sors of cytokine signaling (SOCS) proteins have deﬁned an
important additional mechanism for the negative regulation
of the JAK/STAT pathway [8,9]. However, the role of SOCS
in HG-induced activation of JAK/STAT in human mesangial
cell (HMC) is unknown.
Here we hypothesize that SOCS could down-regulate
HG-induced TGF-b1 expression and inhibit synthesis of ﬁbro-
nectin via regulating the JAK/STAT pathway. To test this
hypothesis, we created HMC stable cell lines overexpressing
SOCS-1 to investigate the eﬀects of SOCS-1 on the expression
of TGF-b1 and synthesis of extracellular matrix protein ﬁbro-
nectin under high glucose condition, and further explored the
activation of JAK/STAT pathway.2. Materials and methods
2.1. Cell line and reagents
Primary HMC was obtained from Clonetics Corporation (Clonetics,
San Diego, CA). RPMI medium1640 was from Gibco Invitrogen Cor-
poration (Grand Island, NY). D-Glucose was obtained from Sigma
(St. Louis, MO). The antibodies against SOCS-1, JAK2, STAT1,
STAT3, c-Fos, c-Jun and ﬁbronectin were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Antiphosphotyrosine antibodies
for JAK2, STAT1 and STAT3 were purchased from Cell Signaling
Technology (Beverly, MA). Lipofectamine 2000, pCR3.1 Vector and
TRIzol reagent were obtained from Invitrogen Life Technologies
(Carlsbad, CA). The RT-PCR system was obtained from Promega
(Madison, WI). TGF-b1 ELISA kit was obtained from R&D Systems
(Minneapolis, MN). Fibronectin ELISA system was purchased from
Chemicon International (Temecula, CA).
2.2. Cell culture and preparation of stable HMC cell lines overexpressing
SOCS-1
HMCs were cultured in RPMI medium 1640 supplemented with
10% fetal bovine serum, 12.5 mmol/l HEPES, 2 mmol/l L-glutamine,
100 U/ml penicillin, and 100 lg/ml streptomycin in a 5% CO2 atmo-
sphere. Stable transfections of HMC with pCR3.1 vector and
pCR3.1/SOCS-1 (kindly provided by Dr. C.J. Auernhammer, Maxim-
ilians-Universita¨t, Germany) were performed with Lipofectamine 2000
according to the manufacturers instructions. Subsequently, cells were
cultured in selection medium containing 0.5 mg/ml geneticin for 4blished by Elsevier B.V. All rights reserved.
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panded in selection medium containing geneticin (0.5 mg/ml). HMCs
were grown to 75–85% conﬂuence, washed once with serum-free RPMI
medium 1640, and then growth-arrested in serum-free RPMI medium
1640 in normal glucose (NG, 5.5 mmol/l) for 24 h to synchronize the
cell growth. After this time period, the media were changed to fresh
serum-free media containing NG, HG, or NG plus mannitol stimula-
tion at indicated time points.
2.3. RT-PCR analysis
Total RNA and then cDNA were prepared from cultured cells using
TRIzol reagent and RT-PCR kits. The primers used were: SOCS-1,
forward 5 0-CGCGACTACCTGAGCTCCTTC-3 0, reverse 5 0-AGTT-
CAGGTCCTGGCTCCAGA-3 0, giving 301 bp PCR product; TGF-
b1, forward 5 0-CCAACTATTGCTTCAGCTCCA-3 0, reverse 5 0-
TTATGCTGGTTGTACAGGG-3 0, giving 196 bp PCR product;
GADPH, forward 5 0-ATCCCATCACCATCTTCCAG-3 0, reverse 5 0-
CCATCACGCCACAGTTTCC-3 0, giving 382 bp PCR product. The
PCR products were subjected to 2% agarose gel electrophoresis and
analyzed with a GDS-8000 Bioimaging system (UVP, upland, CA)
and LabWorks 4.5 software (UVP). RNA expression was quantiﬁed
by comparison with internal-control GAPDH.
2.4. Western blot analysis
Whole cell extracts or the culture medium (50 lg of protein/lane) was
loaded, separated by SDS–PAGE, transferred to PVDF membranes.
The membranes were incubated overnight at 4 C with anti-SOCS-1,
c-Fos, c-Jun, ﬁbronectin andb-actin antibodies. Subsequently, themem-
braneswere incubatedwith goat anti-rabbit IgG or goat anti-mouse IgG
horseradish peroxidase conjugate, and then exposed to X-ray ﬁlm using
enhanced chemiluminescence system. To determine the activation of
JAK/STAT pathway, the membranes were ﬁrstly blotted with phos-
pho-JAK2, STAT1 and STAT3 antibodies and then the phospho-anti-
bodies were stripped oﬀ and blotted with JAK2, STAT1 and STAT3
antibodies. The JAK2, STAT1 and STAT3 phosphorylation were quan-
tiﬁed by comparing the phospho and total protein levels from the same
blot. The intensity of the bands was measured using LabWorks 4.5.
2.5. Enzyme-linked immunosorbent assay
After the cells were cultured in 6-well plates under the diﬀerent
experimental conditions for 48 h, the supernatants were collected.
The TGF-b1 or ﬁbronectin protein was quantiﬁed using a commercial
quantikine enzyme-linked immunosorbent assay (ELISA) kit for TGF-
b1 or competitive sandwich ELISA for ﬁbronectin according to the
manufacturers descriptions.
2.6. Statistical analysis
Statistical analysis was performed by one-way ANOVA. The results
were presented as means ± S.E.M. Statistical signiﬁcance was deﬁned
as P < 0.05.Time (hrs)
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3.1. High glucose induces expression of SOCS-1 in HMC
The synthesis of SOCS-1 protein in HG-stimulated cells was
analyzed by Western blot. The expression level of SOCS-1 pro-
tein increased within 1 h of HG stimulation, peaked at 4 h, and
gradually decreased to baseline at 24 h (Fig. 1A). HG-induced
time-dependant mRNA levels of SOCS-1 were evaluated by
RT-PCR analysis. As shown in Fig. 1B, the increased expres-
sion of SOCS-1 was detected at 1 h and peaked at 4 h. In addi-
tion, no diﬀerences were found in HMC cultured under
conditions of NG or NG plus mannitol among diﬀerent time
points (data not shown).
3.2. HG activates the JAK/STAT pathway in HMC
To determine the eﬀect of HG on activation of the JAK/
STAT signal pathway, we examined the phosphorylation of
JAK2, STAT1, and STAT3 by Western blot analysis. As
shown in Fig. 2, HG-induced time-dependent tyrosine phos-
phorylation of JAK2, STAT1, and STAT3; the phosphoryla-
tion levels were peaked at 12–24 h, and remained at high
levels until 48 h.
3.3. SOCS-1 overexpression inhibits HG-induced tyrosine
phosphorylation of JAK2, STAT1 and STAT3
To investigate the modulation of JAK/STAT signal pathway
by SOCS-1 under HG condition, HMCs were transfected with
expression vector for SOCS-1 (pCR3.1/SOCS-1) or control
vector (pCR3.1). The expression of SOCS-1 protein was 5.8-
fold greater than that of the control group (Fig. 3A). Com-
pared with those of the NG groups, the phosphorylation levels
of JAK2, STAT1, and STAT3 signiﬁcantly increased in HG
group; whereas, overexpression of SOCS-1 in HMCs signiﬁ-
cantly suppressed HG-induced JAK2, STAT1 and STAT3
phosphorylation (Fig. 3B).
3.4. SOCS-1 overexpression reduces the synthesis of TGF-b1
and ﬁbronectin
TGF-b1 levels in the culture medium were measured with
ELISA. A signiﬁcant increase in TGF-b1 protein was seen
after HMCs were cultured under HG condition at 48 h,
whereas the HG-induced overexpression of TGF-b1 wasS-1
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Fig. 2. Time course of the activation of JAK2/STAT by HG in HMCs.
The expression levels of p-JAK2, p-STAT1, p-STAT3, JAK2, STAT1
and STAT3 were analyzed by Western blot in HMCs incubated with
HG at indicated times (0–48 h). Values are expressed as mean-
s ± S.E.M. *P < 0.05, **P < 0.01 vs. control (0 h).
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Fig. 3. Eﬀects of SOCS-1 overexpression on HG-induced
tyrosine phosphorylation of JAK2, STAT1 and STAT3 in HMCs.
(A) Expression of SOCS-1 was analyzed by Western blot. (B)
Expression levels of p-JAK2, p-STAT1, p-STAT3, JAK2, STAT1
and STAT3 were analyzed by Western blot. NG: HMCs incubated
with 5.5 mM D-glucose; HG: HMCs incubated with 30 mM D-glucose;
HG + S1: HMCs transfected with pCR3.1/SOCS-1 and incubated with
30 mM D-glucose; HG + V: HMCs transfected with pCR3.1 vector
and incubated with 30 mM D-glucose. Values are expressed as
means ± S.E.M. **P < 0.01 vs. NG, #P < 0.05 vs. HG + vector.
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Meanwhile, HMCs in HG group showed a signiﬁcant higher
mRNA level of TGF-b1 than those in NG group (P < 0.01);
and the transfection with pCR3.1/SOCS-1 signiﬁcantly de-
creased the HG-induced overexpression of TGF-b1 mRNA
in the HMC (Fig. 4B).
We also examined the concentration of the ﬁbronectin in the
culture medium of the HMCs with ELISA and Western blot.
We found that the HMCs transfected with empty vector ex-
posed to HG showed higher level of ﬁbronectin than those cul-
tured under NG condition at 48 h. Compared to HG-inducedoverexpression of ﬁbronectin in the HMCs transfected with
pCR3.1, the expression of ﬁbronectin decreased signiﬁcantly
in SOCS-1 overexpressing HMCs (Fig. 5A and B).
3.5. SOCS-1 overexpression inhibits the HG-induced
overexpression of c-Fos and c-Jun
HG-induced an obviously increased expression of c-Fos and
c-Jun in HMCs transfected with pCR3.1, and the overexpres-
sion of c-Fos and c-Jun protein under HG condition was sig-
niﬁcantly inhibited by transfection with pCR3.1/SOCS-1
(Fig. 6).
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(NG), NG plus 24.5 mMmannitol (M) or 30 mM D-glucose (HG), and
control HMC clones (pCR3.1 vector, V) and SOCS-1 (pCR3.1/SOCS-
1, S1) overexpressing clones were incubated with HG for 48 h.
Secretion of ﬁbronectin was evaluated by ELISA (A, n = 6) and
Western analysis (B, n = 6). Values are expressed as means ± S.E.M.
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Fig. 6. Eﬀects of SOCS-1 overexpression on HG-induced c-Fos and c-
Jun expression in HMCs. HMCs were incubated with 5.5 mM D-
glucose (NG), NG plus 24.5 mM mannitol (M) or 30 mM D-glucose
(HG), and control HMC clones (pCR3.1 vector, V) and SOCS-1
(pCR3.1/SOCS-1, S1) overexpressing clones were incubated with HG
for 24 h. The expression of c-Fos and c-Jun was analyzed by Western
blot (n = 6). (A) Representative photograph; (B) quantitative data.
Values are expressed as means ± S.E.M. **P < 0.01 vs. NG, #P < 0.05
vs. HG + vector.
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The results of these experiments demonstrate that
overexpression of SOCS-1 in human glomerular mesangial
cells suppresses HG-induced JAK2/STAT activation and over-
production of TGF-b1 and ﬁbronectin.
The JAK/STAT pathway is an important link between cell
surface receptors and nuclear transcriptional events leading
to cell growth [3]. The JAK/STAT pathway, especially the
JAK2–STAT1-dependent pathway, contributes to HG stimu-
lating TGF-b and ﬁbronectin production in cultured rat kid-
ney glomerular mesangial cells [4]. Therefore, it appears that
the activation of JAK2 and STAT proteins by hyperglycemia
might play an important role in both promoting cell prolifera-
tion and the synthesis of ECM molecules. Thus the activation
of JAK/STAT may be one of the major mechanisms involved
in high glucose-induced glomerular injury [3]. The blockade of
JAK/STAT may be an eﬀective method to therapy diabetic
nephropathy.
SOCS-1, also called STAT-induced STAT inhibitor-1 (SSI-
1) and Jak-binding protein (JAB), was initially identiﬁed as
an intracellular negative feedback molecule that inhibits
JAK/STAT signaling initiated by various stimuli, including
3488 Y. Shi et al. / FEBS Letters 582 (2008) 3484–3488IFN-c, IL-4, IL-6 and leukemia-inhibitory factor (LIF)
[8,10,11]. SOCS-1 inhibits cytokine signaling by interaction
of its SH2 domain with phosphorylated Tyr1007 of JAK2
[12]. The role of ANG II and SOCS in renal diseases has also
been investigated [13]. In cultured mesangial and tubular epi-
thelial cells, overexpression of SOCS proteins prevented
ANG II-induced STAT activation. In rats infused with ANG
II, SOCS-1 and SOCS-3 are enhanced via JAK2/STAT1 after
activation of the AT1 receptor [13]. Evidence is emerging for
the involvement of SOCS proteins in ischemic acute renal fail-
ure and immune renal injury [14–16]. In this article, we show
that SOCS-1 (gene and protein) was induced by HG, suggest-
ing that the SOCS family is involved in the HG actions in
HMC. Our results demonstrated that overexpression of
SOCS-1 inhibited HG-induced JAK2, STAT1, and STAT3
phosphorylation and production of TGF-b1 and extracellular
matrix protein ﬁbronectin. These results suggest that the inhib-
itory eﬀects of SOCS-1 to HG-induced production of TGF-b1
and ﬁbronectin may be via inhibiting the activation of the
JAK/STAT signaling pathway.
The key player in the development of pathogenesis in dia-
betic nephropathy is TGF-b, as reported in many in vitro
and in vivo studies [17,18]. HG has been shown to trigger a ser-
ies of events, including protein kinase C and MAP kinase acti-
vation, plus increased expression of c-Fos and c-Jun proto-
oncogenes, which form a heterodimer, AP-1, that activates
the TGF-b gene promoter [19,20]. Some data suggest that pro-
gressive ECM accumulation can be detected by increasing lev-
els of c-Fos and c-Jun in mesangial cell under high glucose and
diabetic rat kidneys [2,21]. Our ﬁndings in the current study
demonstrated that overexpression of SOCS-1 prevented HG-
induced c-Fos and c-Jun expression.
In summary, our data demonstrate that SOCS-1 can sup-
press high glucose-induced TGF-b1 and extracellular matrix
protein ﬁbronectin expression in human mesangial cells. The
results provide evidence that SOCS-1 might be a potential
molecular target to diabetic nephropathy in gene therapy.
Thus, we can speculate that induction of SOCS proteins in
the kidney may be a therapeutic strategy for diabetic nephro-
pathy.
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